Article info
PDFPostScript
Letters
Photodynamic therapy may worsen the prognosis of highly myopic choroidal neovascularisation treated by intravitreal bevacizumab
- Correspondence to Dr J M Ruiz-Moreno, Departamento de Ciencias Médicas, Facultad de Medicina, Avda de Almansa, 14, 02006 Albacete, Spain; josemaria.ruiz{at}uclm.es
Citation
Photodynamic therapy may worsen the prognosis of highly myopic choroidal neovascularisation treated by intravitreal bevacizumab
Publication history
- Accepted March 4, 2009
- First published November 25, 2009.
Online issue publication
March 22, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
BMJ Publishing Group Ltd. All rights reserved.